X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB LUPIN LTD UNICHEM LAB/
LUPIN LTD
 
P/E (TTM) x 283.3 41.8 677.1% View Chart
P/BV x 0.7 2.6 25.2% View Chart
Dividend Yield % 2.6 0.6 403.5%  

Financials

 UNICHEM LAB   LUPIN LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
LUPIN LTD
Mar-18
UNICHEM LAB/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs3821,465 26.1%   
Low Rs234727 32.2%   
Sales per share (Unadj.) Rs116.3349.6 33.3%  
Earnings per share (Unadj.) Rs-18.95.6 -340.4%  
Cash flow per share (Unadj.) Rs-11.729.6 -39.7%  
Dividends per share (Unadj.) Rs5.005.00 100.0%  
Dividend yield (eoy) %1.60.5 355.8%  
Book value per share (Unadj.) Rs381.0300.3 126.9%  
Shares outstanding (eoy) m70.34452.08 15.6%   
Bonus/Rights/Conversions BBESOPS-  
Price / Sales ratio x2.63.1 84.5%   
Avg P/E ratio x-16.3197.2 -8.3%  
P/CF ratio (eoy) x-26.237.1 -70.8%  
Price / Book Value ratio x0.83.6 22.2%  
Dividend payout %-26.490.0 -29.4%   
Avg Mkt Cap Rs m21,668495,502 4.4%   
No. of employees `0002.317.0 13.4%   
Total wages/salary Rs m2,00628,647 7.0%   
Avg. sales/employee Rs Th3,587.89,273.6 38.7%   
Avg. wages/employee Rs Th880.01,681.0 52.4%   
Avg. net profit/employee Rs Th-583.7147.4 -395.9%   
INCOME DATA
Net Sales Rs m8,180158,042 5.2%  
Other income Rs m6101,504 40.6%   
Total revenues Rs m8,790159,545 5.5%   
Gross profit Rs m-1,32031,475 -4.2%  
Depreciation Rs m50510,859 4.7%   
Interest Rs m802,044 3.9%   
Profit before tax Rs m-1,29520,076 -6.5%   
Minority Interest Rs m0-71 0.0%   
Prior Period Items Rs m-235 -6.3%   
Extraordinary Inc (Exp) Rs m0-14,644 0.0%   
Tax Rs m332,885 1.2%   
Profit after tax Rs m-1,3312,513 -53.0%  
Gross profit margin %-16.119.9 -81.0%  
Effective tax rate %-2.614.4 -18.0%   
Net profit margin %-16.31.6 -1,023.4%  
BALANCE SHEET DATA
Current assets Rs m23,318122,095 19.1%   
Current liabilities Rs m4,63550,956 9.1%   
Net working cap to sales %228.445.0 507.4%  
Current ratio x5.02.4 209.9%  
Inventory Days Days12285 143.9%  
Debtors Days Days121120 101.3%  
Net fixed assets Rs m8,163129,876 6.3%   
Share capital Rs m141904 15.6%   
"Free" reserves Rs m26,660134,866 19.8%   
Net worth Rs m26,801135,771 19.7%   
Long term debt Rs m364,245 0.0%   
Total assets Rs m31,890263,054 12.1%  
Interest coverage x-15.210.8 -140.2%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.30.6 42.7%   
Return on assets %-3.91.7 -226.5%  
Return on equity %-5.01.9 -268.3%  
Return on capital %-4.53.7 -122.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,35653,141 8.2%   
Fx outflow Rs m019,335 0.0%   
Net fx Rs m4,35633,807 12.9%   
CASH FLOW
From Operations Rs m-1,12317,512 -6.4%  
From Investments Rs m16,487-14,073 -117.2%  
From Financial Activity Rs m-8,811-14,921 59.1%  
Net Cashflow Rs m6,552-11,482 -57.1%  

Share Holding

Indian Promoters % 50.1 46.6 107.5%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 15.1 11.3 133.6%  
FIIs % 3.0 31.9 9.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 10.1 313.9%  
Shareholders   20,176 98,259 20.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  PANACEA BIOTECH  CADILA HEALTHCARE  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views on News

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 15, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS